These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3363634)

  • 1. Cells invading tumors: strategies for the identification and expansion of tumor reactive lymphocytes.
    Lotze MT; Ross WG; Tomita S; Custer MC
    Transplant Proc; 1988 Apr; 20(2):326-31. PubMed ID: 3363634
    [No Abstract]   [Full Text] [Related]  

  • 2. Reactivity of lymphocytes from normal persons on cultured tumor cells.
    Takasugi M; Mickey MR; Terasaki PI
    Cancer Res; 1973 Nov; 33(11):2898-902. PubMed ID: 4748446
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
    Vilien M
    Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
    [No Abstract]   [Full Text] [Related]  

  • 4. Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes.
    Rabinowich H; Cohen R; Bruderman I; Steiner Z; Klajman A
    Cancer Res; 1987 Jan; 47(1):173-7. PubMed ID: 3491673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytotoxic activity of lymphoid cells in cancer].
    Kamenetz LIa; Grinevich IuA
    Vopr Onkol; 1980; 26(7):81-6. PubMed ID: 6996321
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro immunization to cultured human tumor cells.
    Sharma B; Terasaki PI
    Cancer Res; 1974 Jan; 34(1):115-8. PubMed ID: 4129196
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific antibody activation of lymphocytes for cell-mediated cytotoxicity against cultured target cells.
    Takasugi M; Kinoshita K
    J Natl Cancer Inst; 1974 Dec; 53(6):1539-44. PubMed ID: 4474407
    [No Abstract]   [Full Text] [Related]  

  • 8. An approach for the generation of effector lymphocytes from tumor-bearing hosts for the adoptive immunotherapy of established tumors.
    Shu SY; Chou T
    Prog Clin Biol Res; 1987; 244():27-37. PubMed ID: 3498953
    [No Abstract]   [Full Text] [Related]  

  • 9. Interpretation of lymphocytotoxicity assays and the demonstration of auto-tumor reactive lymphocytes in patients: central issues of present day tumor immunology.
    Klein E
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):385-98. PubMed ID: 6085522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
    Mogi S; Ebata T; Setoguchi Y; Fujime M; Heike Y; Kohsaka T; Yagita H; Okumura K; Azuma M
    Clin Cancer Res; 1998 Mar; 4(3):713-20. PubMed ID: 9533541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immunity in cancer patients against embryonal cells.
    Fossati G; Canevari S; Della Porta G
    J Natl Cancer Inst; 1973 Aug; 51(2):667-9. PubMed ID: 4765379
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental and clinical data for the role of NK-cells in immunosurveillance.
    Klein E; Vánky F; Masucci MG; Bejarano MT
    Behring Inst Mitt; 1984 May; (74):140-8. PubMed ID: 6206839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth-inhibition effect of lymph-node cells from cancer patients on autochthonous tumor cell.
    Orita K; Kobayashi M; Konaga E; Kolumai Y; Hiramatsu M
    Acta Med Okayama; 1973 Dec; 27(5):133-40. PubMed ID: 4273582
    [No Abstract]   [Full Text] [Related]  

  • 14. Interleukin-2 activated cytotoxic lymphocytes and their application in the intraoperative immunotherapy of local tumors.
    Grimm EA
    Prog Clin Biol Res; 1987; 244():185-95. PubMed ID: 3498948
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of target cells, monocytes, and Fc receptor-bearing lymphocytes in human spontaneous cell-mediated cytotoxicity and antibody-dependent cellular cytotoxicity.
    de Vries JE; Mendelsohn J; Bont WS
    J Immunol; 1980 Jul; 125(1):396-405. PubMed ID: 7381206
    [No Abstract]   [Full Text] [Related]  

  • 16. [In vitro biological mechanism of cytotoxic effects of lymphoblastoid cells on human tumor cells (author's transl)].
    Kimoto T; Nishitani K; Hyodo F
    Rinsho Byori; 1977 Jul; 25(7):525-31. PubMed ID: 916240
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune responses of human lymphocytes in vitro.
    Haynes BF; Katz P; Fauci AS
    Prog Clin Immunol; 1980; 4():23-62. PubMed ID: 6992219
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cellular immunity to tumor antigens].
    Hellström KE; Hellström I
    Lakartidningen; 1974 Feb; 71(6):473-8. PubMed ID: 4837237
    [No Abstract]   [Full Text] [Related]  

  • 19. Phagocytic cells as effectors in a cell-mediated immunity system.
    Dennert G; Lennox ES
    J Immunol; 1973 Dec; 111(6):1844-54. PubMed ID: 4543031
    [No Abstract]   [Full Text] [Related]  

  • 20. Workshop in human tumor immunology.
    Oettgen HF; Bean MA; Klein G
    Cancer Res; 1972 Dec; 32(12):2845-53. PubMed ID: 4345410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.